Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

All the vital news, analysis, and commentary curated by our industry experts.

$2500

Buy Report View Sample

Published: May 10, 2024 Report Code: GDME1739EPD-ST

Report Overview
Key Players
Table of Contents
Table
Figures

Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. GlobalData’s Medical Devices sector report, “Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update” provides comprehensive information about the Aortic and Vascular Graft Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Aortic and Vascular Graft Devices report provides key information and data related to:
Extensive coverage of the Aortic and Vascular Graft Devices under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Aortic and Vascular Graft Devices pipeline products.
Review of Recent Developments in the segment / industry
The Aortic and Vascular Graft Devices report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Aortic and Vascular Graft Devices under development _x000D_

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities_x000D_

– The report reviews the major players involved in the development of Aortic and Vascular Graft Devices and list all their pipeline projects_x000D_

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage_x000D_

– The report provides key clinical trial data of ongoing trials specific to pipeline products_x000D_

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to – _x000D_

– Formulate significant competitor information, analysis, and insights to improve R&D strategies_x000D_

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage_x000D_

– Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development_x000D_

– Develop market-entry and market expansion strategies_x000D_

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline_x000D_

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Acro Biomedical Co Ltd
BioLife4D Corp
Cook Medical Inc
Drexel University
Endomimetics LLC
Endoron Medical Ltd
Humacyte Inc
Innoventric Ltd
Merit Medical Systems Inc
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Stanford University
Strait Access Technologies (Pty) Ltd
University of Toledo
Vascular Graft Solutions Ltd
Verigraft AB

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Aortic and Vascular Graft Devices Overview 8

3 Products under Development 9

3.1 Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 9

3.2 Aortic and Vascular Graft Devices – Pipeline Products by Territory 10

3.3 Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 11

3.4 Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 12

3.5 Aortic and Vascular Graft Devices – Ongoing Clinical Trials 13

4 Aortic and Vascular Graft Devices – Pipeline Products under Development by Companies 14

4.1 Aortic and Vascular Graft Devices Companies – Pipeline Products by Stage of Development 14

4.2 Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 15

5 Aortic and Vascular Graft Devices Companies and Product Overview 16

5.1 Acro Biomedical Co Ltd Company Overview 16

5.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 BioLife4D Corp Company Overview 17

5.2.1 BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Cook Medical Inc Company Overview 18

5.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Drexel University Company Overview 19

5.4.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Endomimetics LLC Company Overview 20

5.5.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Endoron Medical Ltd Company Overview 21

5.6.1 Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Humacyte Inc Company Overview 22

5.7.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 Innoventric Ltd Company Overview 23

5.8.1 Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.9 Merit Medical Systems Inc Company Overview 26

5.9.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview 30

5.10.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Stanford University Company Overview 31

5.11.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Strait Access Technologies (Pty) Ltd Company Overview 32

5.12.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 University of Toledo Company Overview 33

5.13.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Vascular Graft Solutions Ltd Company Overview 34

5.14.1 Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 Verigraft AB Company Overview 37

5.15.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview 37

6 Aortic and Vascular Graft Devices- Recent Developments 40

6.1 Apr 24, 2024: Meihua International Medical Technologies Reports 2023 Financial Year Results 40

6.2 Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings 42

6.3 Oct 31, 2023: Meihua International Medical Technologies, Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device 43

6.4 Oct 16, 2023: Humacyte Publishes Preclinical Results Showing Human Acellular Vessel (HAV) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model 43

6.5 Oct 15, 2023: Shanghai Kindly Medical Instruments Co. Notice of 2023 First Extraordinary General Meeting 44

6.6 Oct 05, 2023: Shanghai Kindly Medical Instruments Co. Announces 2022 Annual Report 44

6.7 Oct 02, 2023: Swedish Personalized Tissue Graft Company Verigraft Reports Promising Interim Results From a First-In-Man Study in Patients With Deep Venous Insufficiency at 2023 Cell & Gene Meeting on the Mesa 45

6.8 Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman 46

6.9 Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman 48

6.10 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend 49

7 Appendix 51

7.1 Methodology 51

7.2 About GlobalData 54

7.3 Contact Us 54

7.4 Disclaimer 54

Table

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 9

Aortic and Vascular Graft Devices – Pipeline Products by Territory 10

Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 11

Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 12

Aortic and Vascular Graft Devices – Ongoing Clinical Trials 13

Aortic and Vascular Graft Devices Companies – Pipeline Products by Stage of Development 14

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 15

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

ACROARTERY – Product Status 16

ACROARTERY – Product Description 16

BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview 17

Cardiac Graft – Product Status 17

Cardiac Graft – Product Description 17

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Zenith Eterna – Product Status 18

Zenith Eterna – Product Description 18

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 19

Hydrogel-Based Chemically-Eluting Shunt Prosthesis – Product Status 19

Hydrogel-Based Chemically-Eluting Shunt Prosthesis – Product Description 19

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Stent Graft – Product Status 20

Stent Graft – Product Description 20

Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

Aortoseal – Product Status 21

Aortoseal – Product Description 21

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Humacyl Graft – Pediatric Heart Surgery – Product Status 22

Humacyl Graft – Pediatric Heart Surgery – Product Description 22

Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Trillium – Product Status 23

Trillium – Product Description 23

Innoventric Ltd – Ongoing Clinical Trials Overview 24

Trillium – Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR) 25

Trillium – Prospective, Single Arm, Multi-center, First-in-human (FIH) Study to Assess the Safety and Performance of the Innoventric Trillium Stent Graft for the Treatment of Severe Tricuspid Regurgitation (TR) 25

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Product Status 26

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Product Description 27

Merit Medical Systems Inc – Ongoing Clinical Trials Overview 28

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients: The WAVE Study 29

Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Aortic Vascular Intervention Device – Product Status 30

Aortic Vascular Intervention Device – Product Description 30

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 31

Geometric Aortic Graft – Product Status 31

Geometric Aortic Graft – Product Description 31

Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

TEVAR/EVAR Molding Balloon – Product Status 32

TEVAR/EVAR Molding Balloon – Product Description 32

University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 33

Aortic Endograft Fenestration Device – Product Status 33

Aortic Endograft Fenestration Device – Product Description 33

Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

VEST – Product Status 34

VEST – Product Description 34

Vascular Graft Solutions Ltd – Ongoing Clinical Trials Overview 35

VEST – A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support 36

Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview 37

P-TEV – Product Status 37

P-TEV – Product Description 37

Verigraft AB – Ongoing Clinical Trials Overview 38

P-TEV – Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency 39

Glossary 53

Figures

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 8

Aortic and Vascular Graft Devices – Pipeline Products by Territory 9

Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 10

Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 11

Aortic and Vascular Graft Devices – Ongoing Clinical Trials 12

Frequently asked questions

Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports

Currency USD

Single User

$2,500

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

Assess the relevance of the report
Evaluate the quality of the report
Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Aortic and Vascular Graft Devices reports

Medical Devices

Germany Surgical Stapling Devices Market Size (Value, Volume, ASP) by…

Medical Devices

India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…

Medical Devices

Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

Access a live Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Aortic and Vascular Graft Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Scope

Reasons to Buy

Table of Contents

Table

Figures

Frequently asked questions

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Sample Report

Below is a sample report to understand what you are buying

Related reports